Detalles de la búsqueda
1.
Inhibiting PRMT5 induces DNA damage and increases anti-proliferative activity of Niraparib, a PARP inhibitor, in models of breast and ovarian cancer.
BMC Cancer
; 23(1): 775, 2023 Aug 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37596538
2.
Long-term outcomes in patients with COPD treated with non-invasive ventilation for acute hypercapnic respiratory failure.
Ir J Med Sci
; 2024 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38744793
3.
Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell-Mediated Antitumor Immune Responses.
Cancer Immunol Res
; 10(4): 420-436, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35181787
4.
The effects of using ALD-grown ZnO buffer layers on the properties of indium tin oxide grown by chemical solution deposition.
J Nanosci Nanotechnol
; 11(9): 8354-7, 2011 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22097583
5.
Injuries outside of horseracing: is it time to focus on injury prevention of jockeys outside of races?
Phys Sportsmed
; 49(1): 45-50, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32326866
6.
Functional proteomics interrogation of the kinome identifies MRCKA as a therapeutic target in high-grade serous ovarian carcinoma.
Sci Signal
; 13(619)2020 02 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-32071169
7.
Targeted blockade of HSP90 impairs DNA-damage response proteins and increases the sensitivity of ovarian carcinoma cells to PARP inhibition.
Cancer Biol Ther
; 20(7): 1035-1045, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30929564
8.
Fibroblast activation in sarcoidosis as assessed by 68Ga-FAPI (fibroblast activation protein inhibitor)-46 PET/CT.
QJM
; 2024 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38608203
9.
Anti-tumor Activity of the Type I PRMT Inhibitor, GSK3368715, Synergizes with PRMT5 Inhibition through MTAP Loss.
Cancer Cell
; 36(1): 100-114.e25, 2019 07 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31257072
10.
NEDD9 promotes oncogenic signaling, a stem/mesenchymal gene signature, and aggressive ovarian cancer growth in mice.
Oncogene
; 37(35): 4854-4870, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29773902
11.
In Vitro and In Vivo evaluation of a novel folate-targeted theranostic nanoemulsion of docetaxel for imaging and improved anticancer activity against ovarian cancers.
Cancer Biol Ther
; 19(7): 554-564, 2018 07 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29737910
12.
Follicle-Stimulating Hormone Receptor Is Expressed by Most Ovarian Cancer Subtypes and Is a Safe and Effective Immunotherapeutic Target.
Clin Cancer Res
; 23(2): 441-453, 2017 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27435394
13.
Resistance to BET Bromodomain Inhibitors Is Mediated by Kinome Reprogramming in Ovarian Cancer.
Cell Rep
; 16(5): 1273-1286, 2016 08 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27452461
14.
The BRCA1-Δ11q Alternative Splice Isoform Bypasses Germline Mutations and Promotes Therapeutic Resistance to PARP Inhibition and Cisplatin.
Cancer Res
; 76(9): 2778-90, 2016 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27197267
15.
Targeted Blockade of JAK/STAT3 Signaling Inhibits Ovarian Carcinoma Growth.
Mol Cancer Ther
; 14(4): 1035-47, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25646015
16.
Network analysis identifies an HSP90-central hub susceptible in ovarian cancer.
Clin Cancer Res
; 19(18): 5053-67, 2013 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23900136
17.
Combined in vivo molecular and anatomic imaging for detection of ovarian carcinoma-associated protease activity and integrin expression in mice.
Neoplasia
; 14(6): 451-62, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22787427
18.
Defining natural history: assessment of the ability of college students to aid in characterizing clinical progression of Niemann-Pick disease, type C.
PLoS One
; 6(10): e23666, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21984891
Resultados
1 -
18
de 18
1
Próxima >
>>